# Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost

> **NCT01444040** · PHASE4 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 196 (actual)

## Conditions studied

- Open-angle Glaucoma

## Interventions

- **DEVICE:** iStent inject
- **DRUG:** Travoprost

## Key facts

- **NCT ID:** NCT01444040
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2019-03-28
- **Final completion:** 2019-03-28
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2022-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444040, "Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01444040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*